Naslov
The prevalence of major comorbidities among people living with HIV in Croatia

Autori
Benković, Ivana ; Močibob, Loris ; Zekan, Šime ; Lukas, Davorka ; Bogdanić, Nikolina ; Begovac, Josip

Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni

Skup
HIV Glasgow

Mjesto i datum
Online, 05.10.2022. - 08.10.2022

Vrsta sudjelovanja
Poster

Vrsta recenzije
Međunarodna recenzija

Ključne riječi
Prevalence ; comorbidities ; HIV ; Croatia

Sažetak
Background: The burden of HIV care is influenced by AIDS-related and non-AIDS-related comorbidities (NAIDSC). All PLWHIV in Croatia are treated at the University Hospital for Infectious Diseases (UHID) in Zagreb. The aim of our study was to provide national period prevalence data of major comorbidities in PLWHIV in Croatia in 2019. Materials and methods: Included were Croatian citizens/residents ≥18 years who were seen at UHID in 2019 who ever had at least two visits >6 months apart. The following comorbidities were analysed: AIDS-defining diseases, myocardial infarction (MI), stroke, invasive cardiovascular procedures (ICPs), cancer both AIDS- (ADC) and non-AIDS- defining (NADC), end-stage liver disease (ESLD), endstage renal disease (ESRD), bone fractures and diabetes mellitus. All major comorbidities were expressed as percentages of the total HIV population in care and those ≥50 years old. Results: Of 1168 PLWHIV included into the study, 90.2% (1053/ 1168) were male, median age was 44.6 (Q1 to Q3: 37.6 to 53.5) with age ≥50 years in 405 (34.7%), main mode of transmission was sex between men (858, 73.5%) and heterosexual contact (239, 20.5%). Median age of those ≥50 was 56.5 years. The overall duration of HIV-1 infection was 7.5 (for those ≥50 years: 13.2) years, exposure to antiretrovirals was 6.4 (for those ≥50 years: 11.2) years. Chronic hepatitis B had 32 (2.7%) persons ; hepatitis C antibodies were positive in 57 (4.9%) of whom 39 (68.4%) had an undetectable HCV viral load. Overall major NAIDSC (without skin cancer) were present in 175 (15.0%, 95% CI: 13.0 to 17.2 ; in those ≥50 years: N = 90, 22.2%) persons (Table 1). NAIDSC occurred after an HIV- diagnosis in 100 (8.6%) and 74 (18.3% of those ≥50 years old) ; the most frequent being diabetes followed by ICP, MI and NADC. Of NADC after an HIV-diagnosis Hodgkin’s lymphoma was most frequent (n = 5). Fractures were predominantly traumatic and there were four cases of ESRD and no cases of ESDL. Clinical AIDS and ADC after HIV diagnosis occurred in 90 and 18 persons, respectively. Conclusions: The overall prevalence of major clinical NAIDSC was 15.0% for the total HIV population and 22.2% for those ≥50 years old. The prevalence of individual major NAIDSC for the whole HIV population ranged from 0.0% to 3.8% with diabetes being the most frequent.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti

POVEZANOST RADA